Peter Thiel acquires 7.5% stake in Ethereum treasury ETHZilla
Key Takeaways
- Peter Thiel has disclosed a 7.5% stake in ETHZilla, which trades under the ticker ATNF.
- Thiel and his investor group reported beneficial ownership of over 11 million shares of 180 Life Sciences.
Share this article
Peter Thiel, the billionaire tech investor and co-founder of PayPal and Palantir, is part of an investor group that holds a 7.5% stake in 180 Life Sciences, which is rebranding as ETHZilla, an Ethereum-focused corporate treasury vehicle, according to a new SEC disclosure .
Shares of 180 Life Sciences (ATNF) jumped over 11% at Monday’s close and surged roughly 57% in overnight trading, Yahoo Finance data shows.
180 Life Sciences announced its Ethereum treasury plan in late July.
On Monday, the biotech firm said it sold $156 million in senior secured convertible notes due 2028 to an institutional investor, following a recent $425 million private placement. Proceeds will primarily fund Ethereum purchases, yield-bearing assets, and the company’s iGaming operations, while monetizing legacy biotech IP.
Thiel’s investor group now has stakes in two Ethereum treasury companies. In mid-July, he reported holding over 9% of Tom Lee’s BitMine Immersion , currently the biggest corporate ETH holder with close to $5 billion in its treasury.
Share this article
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As economic fissures deepen, Bitcoin may become the next "pressure relief valve" for liquidity
Cryptocurrency is one of the few areas where value can be held and transferred without relying on banks or governments.

Why do 90% of project TGEs end in disappointment?
Doing these things is the prerequisite for a successful TGE.

ETH volatility surges: On-chain liquidity and leverage risks trigger market turbulence
Bitcoin hits 6-month low as AI fears add to risk-off mood: How are pro traders positioned?
